Details of the Drug

General Information of Drug (ID: DM6FOK4)

Drug Name

NeoTCR-P1

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

TCR-T cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03970382) A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors. U.S. National Institutes of Health.